Hear AtLast Holdings, Inc. (HRAL)
USD 0.0
(-10.0%)
USD 0.0
(-10.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 37.66 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2021 Q1 | 50.24 Thousand USD | 33.41% |
| 2021 FY | - USD | -100.0% |
| 2021 Q2 | 50.24 Thousand USD | 0.0% |
| 2021 Q4 | - USD | -100.0% |
| 2021 Q3 | 39.43 Thousand USD | -21.53% |
| 2020 Q4 | 37.66 Thousand USD | 4.92% |
| 2020 Q3 | 35.89 Thousand USD | 2.36% |
| 2020 FY | 37.66 Thousand USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q2 | 35.07 Thousand USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | 100.0% |
| Ansell Limited | 457.04 Million USD | 100.0% |
| Ansell Limited | 457.9 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 43.33 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | 27.89 Thousand USD | 100.0% |
| Psykey, Inc. | 49.94 Thousand USD | 100.0% |
| ConvaTec Group Plc | 395.54 Million USD | 100.0% |
| ConvaTec Group Plc | 396.1 Million USD | 100.0% |
| Encision Inc. | 1.4 Million USD | 100.0% |
| Golden Valley Development, Inc | - USD | NaN% |
| Innovative MedTech Inc. | -9294.00 USD | 100.0% |
| LifePoint, Inc. | 2.3 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | 91.88 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | 49.87 Million USD | 100.0% |
| Sector 10, Inc. | - USD | NaN% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 100.0% |
| SheerVision, Inc. | 339.66 Thousand USD | 100.0% |
| United Health Products, Inc. | 33.59 Thousand USD | 100.0% |
| Vasamed, Inc. | 449.02 Thousand USD | 100.0% |
| Wearable Health Solutions, Inc. | 8555.00 USD | 100.0% |
| Yubo International Biotech Limited | 322.17 Thousand USD | 100.0% |